Advanced Materials in Drug Release and Drug Delivery Systems
Development of new drug molecules is costly and requires longitudinal, wide-ranging studies; therefore, designing advanced pharmaceutical formulations for existing and well-known drugs seems to be an attractive device for the pharmaceutical industry. Properly formulated drug delivery systems can imp...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_76771 | ||
005 | 20220111 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-1059-0 | ||
020 | |a 9783036510583 | ||
020 | |a 9783036510590 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-1059-0 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a TB |2 bicssc | |
100 | 1 | |a Winnicka, Katarzyna |4 edt | |
700 | 1 | |a Winnicka, Katarzyna |4 oth | |
245 | 1 | 0 | |a Advanced Materials in Drug Release and Drug Delivery Systems |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (234 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Development of new drug molecules is costly and requires longitudinal, wide-ranging studies; therefore, designing advanced pharmaceutical formulations for existing and well-known drugs seems to be an attractive device for the pharmaceutical industry. Properly formulated drug delivery systems can improve pharmacological activity, efficacy and safety of the active substances. Advanced materials applied as pharmaceutical excipients in designing drug delivery systems can help solve problems concerning the required drug release-with the defined dissolution rate and at the determined site. Novel drug carriers enable more effective drug delivery, with improved safety and with fewer side effects. Investigations concerning advanced materials represent a rapidly growing research field in material/polymer science, chemical engineering and pharmaceutical technology. Exploring novel materials or modifying and combining existing ones is now a crucial trend in pharmaceutical technology. Eleven articles included in the the Special Issue "Advanced Materials in Drug Release and Drug Delivery Systems" present the most recent insights into the utilization of different materials with promising potential in drug delivery and into different formulation approaches that can be used in the design of pharmaceutical formulations. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Technology: general issues |2 bicssc | |
653 | |a mesoporous silica | ||
653 | |a layer-by-layer | ||
653 | |a FITC-peptide | ||
653 | |a hyaluronic acid | ||
653 | |a multilayer film | ||
653 | |a host-guest interaction | ||
653 | |a total alkaloids from Alstonia scholaris leaves | ||
653 | |a mPEG-PLA | ||
653 | |a microspheres | ||
653 | |a drug release | ||
653 | |a biocompatibility | ||
653 | |a CO administration | ||
653 | |a therapeutic agent | ||
653 | |a pharmaceutical drugs | ||
653 | |a heme oxygenase | ||
653 | |a CO-releasing materials | ||
653 | |a CO-releasing molecules | ||
653 | |a organometallic complexes | ||
653 | |a pharmacokinetic functions | ||
653 | |a pathological role | ||
653 | |a CO kinetic profile | ||
653 | |a cellular targets | ||
653 | |a GQDs | ||
653 | |a real-time tracking | ||
653 | |a optical-magneto nanoparticles | ||
653 | |a in vivo | ||
653 | |a ethylcellulose | ||
653 | |a polymeric material | ||
653 | |a cellulose derivative | ||
653 | |a pharmaceutical excipient | ||
653 | |a hydrogel | ||
653 | |a drug delivery | ||
653 | |a polymer | ||
653 | |a immobilization of drug | ||
653 | |a gelatin | ||
653 | |a gastro-resistant | ||
653 | |a films | ||
653 | |a capsules | ||
653 | |a structure | ||
653 | |a sirolimus | ||
653 | |a electrospinning | ||
653 | |a polycaprolactone | ||
653 | |a 3D matrix | ||
653 | |a drug-eluting stents | ||
653 | |a spray drying | ||
653 | |a microparticles | ||
653 | |a rupatadine fumarate | ||
653 | |a orodispersible minitablets | ||
653 | |a taste masking | ||
653 | |a Bicalutamide | ||
653 | |a Poloxamer® 407 | ||
653 | |a Macrogol 6000 | ||
653 | |a supercritical carbon dioxide | ||
653 | |a solid dispersions | ||
653 | |a dissolution rate | ||
653 | |a amorphization | ||
653 | |a 3D printing | ||
653 | |a fused deposition modeling | ||
653 | |a hot-melt extrusion | ||
653 | |a solid dosage forms | ||
653 | |a itraconazole | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4220 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76771 |7 0 |z DOAB: description of the publication |